Related references
Note: Only part of the references are listed.Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (UGT1A1)
Ken Konaka et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer
Yutaka Negoro et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Adverse effects observed in lung cancer patients undergoing first-line chemotherapy and effectiveness of supportive care drugs in a resource-limited setting
Valliappan Muthu et al.
LUNG INDIA (2019)
Interconversion of two commonly used performance tools: An analysis of 5844 paired assessments in 1501 lung cancer patients
Kuruswamy Thurai Prasad et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2018)
Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key
H. Kaur et al.
INDIAN JOURNAL OF CANCER (2017)
Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy
Yu Bai et al.
ONCOTARGETS AND THERAPY (2017)
Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key
H. Kaur et al.
INDIAN JOURNAL OF CANCER (2017)
Comparison of Symptom Score and Bronchoscopy-Based Assessment With Conventional Computed Tomography-Based Assessment of Response to Chemotherapy in Lung Cancer
Lakshimikant Baburao Yenge et al.
JOURNAL OF GLOBAL ONCOLOGY (2017)
Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer
Navneet Singh et al.
CLINICAL LUNG CANCER (2016)
The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer
Xiao-guang Xiao et al.
ONCOTARGETS AND THERAPY (2015)
Clinical usefulness of testing for UDP glucuronosyltransferase 1 family, polypeptide A1 polymorphism prior to the inititation of irinotecan-based chemotherapy
Taishi Harada et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
Tumor cavitation among lung cancer patients receiving first-line chemotherapy at a tertiary care centre in India: association with histology and overall survival
Navneet Singh et al.
MEDICAL ONCOLOGY (2013)
Management of advanced lung cancer in resource-constrained settings: a perspective from India
Navneet Singh et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Unchanging clinico-epidemiological profile of lung cancer in North India over three decades
Navneet Singh et al.
CANCER EPIDEMIOLOGY (2010)
Phase I/II Pharmacokinetic and Pharmacogenomic Study of UGT1A1 Polymorphism in Elderly Patients With Advanced Non-Small Cell Lung Cancer Treated With Irinotecan
N. Yamamoto et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review
Glenn E. Palomaki et al.
GENETICS IN MEDICINE (2009)
Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer
Ji-Youn Han et al.
LUNG CANCER (2009)
Irinotecan pharmacogenetics:: Influence of pharmacodynamic genes
Janelle M. Hoskins et al.
CLINICAL CANCER RESEARCH (2008)
Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer
Kazuhiro Araki et al.
CANCER SCIENCE (2006)
Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin
Ji-Youn Han et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer
K Sai et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Genetic polymorphisms of UDP-glucuronosyltransferase in Asians: UGT1A1*28 is a common allele in Indians
C Balram et al.
PHARMACOGENETICS (2002)